Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate
(21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Hongbin Sun
- Bruce Moyer
- Christopher Hobbs
- Debjani Pal
- Eddie Lopez Honorato
- Ilias Belharouak
- Jeffrey Einkauf
- Jennifer M Pyles
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Matt Kurley III
- Mike Zach
- Padhraic L Mulligan
- Pradeep Ramuhalli
- Praveen Cheekatamarla
- Rodney D Hunt
- Ruhul Amin
- Ryan Heldt
- Sandra Davern
- Tyler Gerczak
- Vishaldeep Sharma

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

The invention presented here addresses key challenges associated with counterfeit refrigerants by ensuring safety, maintaining system performance, supporting environmental compliance, and mitigating health and legal risks.

Sintering additives to improve densification and microstructure control of UN provides a facile approach to producing high quality nuclear fuels.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Knowing the state of charge of lithium-ion batteries, used to power applications from electric vehicles to medical diagnostic equipment, is critical for long-term battery operation.

The use of Fluidized Bed Chemical Vapor Deposition to coat particles or fibers is inherently slow and capital intensive, as it requires constant modifications to the equipment to account for changes in the characteristics of the substrates to be coated.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence